Add Company
Join Now

Adjuvant Capital Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • Adjuvant Capital's estimated annual revenue is currently $3.5M per year.(i)
  • Adjuvant Capital's estimated revenue per employee is $205,882

Employee Data

  • Adjuvant Capital has 17 Employees.(i)
  • Adjuvant Capital grew their employee count by 6% last year.

Adjuvant Capital's People

NameTitleEmail/Phone
1
Founder and Managing PartnerReveal Email/Phone
2
Venture PartnerReveal Email/Phone
3
PartnerReveal Email/Phone
4
PartnerReveal Email/Phone
5
Life Sciences Venture CapitalReveal Email/Phone
6
Life Sciences Venture CapitalReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.5M180%N/AN/A
#2
N/A19-21%N/AN/A
#3
$7.5M5721%N/AN/A
#4
$11830M3644%$1MN/A
#5
$7.5M4850%$48.1MN/A
#6
$15M12317%N/AN/A
#7
N/A8-88%N/AN/A
#8
N/A24-11%N/AN/A
#9
N/A1614%N/AN/A
#10
$7.5M5320%N/AN/A
Add Company

What Is Adjuvant Capital?

Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$3.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Adjuvant Capital News

2022-04-13 - 20 Things You Didn't Know About AN2 Therapeutics

Other investors include BioRock Ventures, Adjuvant Capital, and Mountain Group Capital, also a lead investor.

2022-03-22 - Form 3 AN2 Therapeutics, Inc. For: Mar 24 Filed by: Aziz Kabeer

Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M17-62%N/A
#2
$1.5M17-11%N/A
#3
$2.1M17-26%N/A
#4
$4.9M17-19%$19.4M
#5
$7.5M17-19%$56.6M